Early Non-invasive Ventilation Outside the Intensive Care Unit (NAVIGATE)

August 5, 2025 updated by: Giovanni Landoni, Università Vita-Salute San Raffaele

Reducing the Need for Intensive Care Unit in Hospitalized Patients With Early Respiratory Failure Using the Non-invasive Ventilation Technique. A Multicentre Randomized Study.

A large multicentre, randomized, controlled trial to demonstrate that non invasive ventilation given at an early stage of acute respiratory failure (ARF) outside the intensive care unit (ICU) can prevent the deterioration of ARF and the need for ICU when compared to the best available treatment usually performed in the non-ICU wards.

Study Overview

Study Type

Interventional

Enrollment (Actual)

520

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Larissa, Greece
        • University of Thessaly
      • Asti, Italy
        • Ospedale Civile di Asti
      • Brescia, Italy
        • Spedali Civili
      • Genova, Italy
        • Ospedali Galliera
      • Genova, Italy
        • ASL 3 Genovese
      • Pisa, Italy
        • AOU Pisana
      • Reggio Calabria, Italy
        • Grande Ospedale Metropolitano
      • Roma, Italy
        • Policlinico A. Gemelli
      • Roma, Italy
        • Aurelia Hospital
      • Torino, Italy
        • Azienda Ospedaliera San Giovanni Battista Molinette
    • MI
      • Milan, MI, Italy, 20132
        • Ospedale San Raffaele di Milano
    • Piemonte
      • Alessandria, Piemonte, Italy, 15121
        • Ospedale Cesare Arrigo
      • Novara, Piemonte, Italy
        • Ospedale di Novara
      • Kazakhstan, Kazakhstan
        • Astana Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Informed consent
  • Age >= 18 years
  • Admission in a non-intensive-care department
  • Radiological evidence of new pulmonary consolidation or atelectasis
  • Peripheral Oxygen saturation less than 92% while breathing room air or PaO2/FiO2 ratio less than 300 at blood gas analysis
  • Decompensated hypercapnia (pCO2 > 45 mmHg and pH < 7.35)
  • Clinical signs of respiratory distress (dyspnoea, utilization of accessory respiratory muscles, paradox movements of thoraco-abdominal wall) in air.

Exclusion Criteria:

  • Respiratory failure due to chronic obstructive pulmonary disease exacerbation, defined as PaCO2 > 45 and pH < 7.35 (in these patients NIV is considered to be the standard/first line treatment and we do not want to deny these patients the opportunity to receive this treatment because of randomization)
  • Severe, hypercapnic ARF defined as PaCO2 > 45 and pH < 7.30
  • Severe, hypoxic ARF defined as PaO2/FiO2 < 200
  • Need for immediate mechanical ventilation or ICU as judged by the ICU physician in charge
  • Extremely poor short term prognosis (imminent death with decision for palliative treatment only)
  • Invasive or non-invasive mechanical ventilation during the same hospitalization due to respiratory failure.
  • Clear contraindication to NIV treatment: respiratory arrest, failure to correct positioning of a face mask, hemodynamic instability due to hypotensive shock, ongoing myocardial ischemia, arrhythmia, massive bleeding from upper gastrointestinal tract, patient uncooperative and upset, inability to protect airways, alterations of deglutition, inability to clear secretion also with external aspiration, multiple organs dysfunction, recent surgery of airways or upper gastrointestinal tract, not-drained pneumothorax, bowel obstruction, active vomit.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NIV
Non-invasive ventilation
Early non-invasive ventilation will be given to patients at an early stage of acute respiratory failure
Other Names:
  • NIV
  • Noninvasive ventilation
Other: Best available treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of patients who will need admission to the Intensive Care Unit care for severe acute respiratory failure
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
participants will be followed for the duration of hospital stay, an expected average of 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2012

Primary Completion (Actual)

August 17, 2023

Study Completion (Actual)

July 18, 2024

Study Registration Dates

First Submitted

March 16, 2012

First Submitted That Met QC Criteria

April 3, 2012

First Posted (Estimated)

April 6, 2012

Study Record Updates

Last Update Posted (Actual)

August 7, 2025

Last Update Submitted That Met QC Criteria

August 5, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Early Acute Respiratory Failure

Clinical Trials on Standard care

Subscribe